Debt Reduction
Berkshire Hathaway’s $9.7 Billion OxyChem Acquisition Signals Buffett Era’s End
Berkshire Hathaway’s purchase of OxyChem for $9.7 billion marks its largest deal in years and may be Warren Buffett’s final major move as CEO, reflecting a strategic shift and leadership transition.
